FDA Adverse Event Injury Summary report: N

IMPELLA

MDR report key: 25145899 · Received May 12, 2026

Report

Report Number
1220648-2026-07746
Event Type
Injury
Date Received
May 12, 2026
Date of Event
May 6, 2026
Report Date
May 11, 2026
Manufacturer
ABIOMED, INC. - 1220648
Product Code
OZD
UDI-DI
00813502012828
PMA / PMN Number
P140003
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING SUBMITTED PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH HAS NOT BEEN INVESTIGATED OR VERIFIED PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ABIOMED INC, OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE PRODUCT, ABIOMED INC, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL REPORT, A FOLLOW-UP REPORT WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 0

A MALE PATIENT UNDERWENT ELECTIVE PLACEMENT OF AN IMPELLA 5.5 DEVICE VIA DIRECT SURGICAL ACCESS TO THE RIGHT SIDE OF THE AORTA, WITH THE PRE-SUPPORT CLINICAL STATE DOCUMENTED AS SCAI SHOCK STAGE D. THE DEVICE IMPLANTED ON (B)(6) 2026 AT 14:05 AND REMAINS ON SUPPORT AT THE TIME OF THIS REPORT. DURING THE CLINICAL COURSE, THE PATIENT EXPERIENCED BLEEDING FROM VENOUS GRAFTS AT THE AORTA, FOR WHICH MULTIPLE BLOOD PRODUCTS WERE ADMINISTERED. THERE WAS NO ALLEGATION OF DEVICE MALFUNCTION AND NO IMPLICATION OF THE IMPELLA SYSTEM IN THE BLEEDING EVENT PER THE REPORTING SOURCE. THE PATIENT REMAINS ON SUPPORT AT THE TIME OF REPORTING. THIS EVENT IS LIKELY ATTRIBUTED TO A CLINICAL COMPLICATION RELATED TO SURGICAL GRAFT BLEEDING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
574082 IMPELLA TEMPORARY NON-ROLLER TYPE LEFT HEART SUPPORT BLOOD PUMP OZD ABIOMED, INC. - 1220648 2027817778 00813502012828

Patients

Seq Age Sex Outcome Treatment
1